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Abstract
At present, there are three ways to determine effectively the quality of the cryopreservation procedure using ovarian tissue
before the re-implantation treatment: evaluation of follicles after post-thawing xenotransplantation to SCID mouse, in-vitro
culture in a large volume of culture medium under constant agitation and culture on embryonic chorio-allantoic membrane
within a hen’s eggs. The aim of this study was to compare the two methods, culture in vitro and culture on embryonic
chorioallantoic membrane (CAM) of cryopreserved human ovarian medulla-contained and medulla-free cortex. Ovarian
fragments were divided into small pieces (1.5–2.061.0–1.260.8–1.5) of two types, cortex with medulla and medulla-free
cortex, frozen, thawed and randomly divided into the following four groups. Group 1: medulla-free cortex cultured in vitro
for 8 days in large volume of medium with mechanical agitation, Group 2: medulla-containing cortex cultured in vitro,
Group 3: medulla-free cortex cultured in CAM-system for 5 days, Group 4: medulla-containing cortex cultured in CAM-
system. The efficacy of the tissue culture was evaluated by the development of follicles and by intensiveness of
angiogenesis in the tissue (von Willebrand factor and Desmin). For Group 1, 2, 3 and 4, respectively 85%, 85%, 87% and 84%
of the follicles were morphologically normal (P.0.1). The immunohistochemical analysis showed that angiogenesis
detected by von Willebrand factor was lower in groups 1 and 3 (medulla-free cortex). Neo-vascularisation (by Desmin) was
observed only in ovarian tissue of Group 4 (medulla-contained cortex after CAM-culture). It appears that the presence of
medulla in ovarian pieces is beneficial for post-thaw development of cryopreserved human ovarian tissue. For medical
practice it is recommended for evaluation of post-warming ovarian tissue to use the CAM-system as a valuable alternative to
xenotransplantation and for cryopreservation of these tissues to prepare ovarian medulla-contained strips.
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Introduction
Cancer is one of the major death causes: in the USA alone a
total of 1,596,670 new cancer cases will be reported in 2011, of
which the projected number of cancer-related deaths were
571,950. Overall cancer incidence rates in women in the USA
have been declining by 0.6% annually since 1998 [1]. At the same
time, the overall incidence rate for cancer in children aged 14
years and younger increased by 0.6% per year between 1998 and
2007 [2].
A similar trend has been observed in Europe. The current
estimate for 2010 for Germany relates to a total of approximately
204,000 cancer cases in women, and every year in Germany,
around 800 girls under age 15 are diagnosed with cancer [3]. At
the same time, the death rate has been decreasing by 1.0% per
year.
Over the past 25 years, there have been significant improve-
ments in the 5-year relative survival rate for all of the major
childhood cancers due to new and improved anti-cancer
treatments. The 5-year relative survival rate for children with
cancer improved from 58% for patients diagnosed between 1975
and 1977 to 82% for those diagnosed between 1999 and 2006 [4].
Due to the increasing of effectiveness of cancer treatments and
positive long-term prognosis for young women, the problem of
post-cancer infertility is playing an increasingly significant role
because chemotherapy can be gonadotoxic and lead to the
functional death of ovaries. Cryopreservation of ovarian tissue
before cancer therapy with re-implantation after convalescence is
the potential key solution of this problem [5–8].
Several cases reporting restoration of ovarian function after re-
implantation of ovarian cortex in patients with premature ovarian
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now baby-born after thawing and transplantation is reality [9–31].
It is such, the final aim of the ovarian tissue cryopreservation is
baby-born. However, a large body of evidence supports the notion
that the primary aim of ovarian tissue cryopreservation should be
for therapeutic purpose (e.g. successful restoration of ovarian
function after thawing and implantation) [32,33].
The process of preparation of ovarian tissue for cryopreserva-
tion requires the separation of cortex from medulla due to the fact
that the majority of follicles are contained in the cortex. However,
the discarded medulla also contains significant numbers of follicles
[34] and, importantly, blood vessels. The presence of the latter
may support neovascularisation in re-implanted tissues.
Part of the ovarian tissue obtained before oncological treatment
is used for routine histological observation, a mandatory procedure
for monitoring and minimising the risks associated with any future
implantation of tissues that could be affected by metastases. After
cryopreservation and storage, some ovarian tissue can be thawed
and cultured in vitro in order both to screen for the presence of
metastases and to monitor follicles. The quality of follicles in the
cultured tissue will indicate whether it is possible to restore a
woman’s reproductive function. At present, there are three ways to
determine effectively the quality of the cryopreservation procedure
using ovarian tissue from a given patient before the re-
implantation treatment: (i) evaluation of follicles after post-thawing
xenotransplantation to SCID mouse [13,35–39], (ii) in-vitro
culture in a large volume of culture medium under constant
agitation [40–49] and (iii) culture on embryonic chorio-allantoic
membrane within a hen’s egg [50]. The CAM system is an
intermediate stage between in-vitro culture and animal experi-
ments, and it could be considered as an interface between in-vitro
and in-vivo models (including xenotransplantation). Importantly, it
does not raise ethical or legal questions, nor does it violate animal
protection laws.
The aim of this study was to compare the two methods, culture
in vitro and culture on embryonic chorioallantoic membrane
(CAM) of cryopreserved human ovarian medulla-containing and
medulla-free cortex.
Materials and Methods
Ethics Statement
The protocol of investigations described in this article was
approved by the Ethics Boards of Universities Cologne (permission
276-03 from 07.07.2003) and Ulm (permission 102/10 from
19.07.2010).
On the behalf of the patients under the age of 18 written
consents were obtained from the next of kin.
Except where otherwise stated, all chemicals were obtained
from Sigma (Sigma Chemical Co., St. Louis, MO, USA).
Tissue collection, dissection, and distribution into groups
Informed written consent for performing of investigations was
obtained from 9 patients aged between 14 and 34 (average
20.064.1 years). According to this protocol 10% of ovarian tissue
was used for patient-oriented research.
For transportation of ovarian tissue from surgical section,
preparation of ovarian strips, freezing, thawing and culture, the
OvarStore
TM kit (Gynemed, Lensahn, Germany) was used. This
kit was developed in Universities Cologne and Ulm in cooperation
with the Gynemed company. The basal medium used for
manipulation of tissues (transport and dissection) was Leibovitz
L-15 with 5% Dextran Serum Substitute (Irvine Scientific, Santa
Ana, CA, USA), referred to below as ‘basal medium’.
Fresh ovarian tissue fragments were transported from the
surgical room to the laboratory within 20 min with temperature
maintained at 32–34uC. Using tweezers and scalpel No 22,
ovarian fragments were dissected and divided into small pieces
of two types, cortex with medulla and medulla-free cortex (1.5–
2.061.0–1.260.8–1.2 mm for medulla-free pieces and 1.5–
2.061.0–1.261.2–1.5 for medulla-containing pieces) and frozen
as described below. After subsequent thawing (procedure de-
scribed below), the pieces were randomly divided into four groups:
medulla-free cortex cultured in vitro in a large volume of medium
with mechanical agitation (Group 1); medulla-containing cortex
cultured in vitro (Group 2); medulla-free cortex cultured in CAM-
system (Group 3); medulla-containing cortex cultured in CAM-
system (Group 4).
From each patient, eight pieces were used for determination of
quality of follicles and angiogenesis: two pieces for each
experimental group, one piece per egg.
Freezing and thawing
The freezing protocol was based on that published by Gosden et
al. [51–53] with some modifications. Pieces of ovarian tissue were
placed at room temperature in 20 ml freezing medium (Gynemed)
composed of basal medium supplemented with 6% dimethyl
sulfoxide, 6% ethylene glycol and 0.15 M sucrose. Then pieces
were put into a standard 1-ml cryo-straw (MTG GmbH,
Bruckberg, Deutschland) previously filled by freezing medium
and frozen in a CTE 2104 freezer (Cryo-Technik-Erlangen,
Hoechstadt, Germany). The freezing program consisted of the
following five stages: (1) start temperature 22uC, (2) cooling from
22uCt o4 uC at a rate of 25uC/min, (3) cooling from 4uCt o27uC
at a rate of 21uC/min, (4) cooling from 27uCt o234uC at a rate
of 20.3uC/min, (5) plunging into liquid nitrogen. It was noted that
at 210uC there was a formation of crystals in the place of
localization of ovarian pieces (this construction of freezer implies
the auto-seeding).
The procedure of thawing was achieved by holding the straws
for 10 s at room temperature followed by immersion in a 100uC
(boiling) water bath for 20 s, and expelling the contents of the
straw into the solution for the removal of cryoprotectants. The
exposure time in the boiling water was visually controlled by the
presence of ice in the medium; as soon as the ice was 2 to 1 mm
apex, the straw was removed from the boiling water, at which
point the final temperature of the medium was between 4 and
10uC. Within 5–10 seconds after thawing, the pieces from the
straw were expelled into 10 ml thawing solution (basal medium
containing 0.5 M sucrose) in a 100 ml specimen container
(Sarstedt, Nuembrecht, Germany). The stepwise dilution of
cryoprotectants was achieved using the same principle as that
used for saturation by ethylene glycol (see Fig. 1 in Isachenko et al.
[40]. The container was placed on a shaker and continuously
agitated with 200 osc/min for 15 min at room temperature.
Stepwise rehydration of the tissue pieces for 30 min at room
temperature was also performed using the same ‘dropping’
methodology [40]: slow addition of basal medium (Gynemed,
see above) to the solution of sucrose with ovarian pieces. For
‘dropping’, we used 50 ml of basal medium in a 50 ml tube
(Greiner Bio-One GmbH, Frickenhausen, Germany). The final
sucrose concentration was 0.083 M, resulting in almost isotonic
conditions. Finally, the pieces were washed thrice each in basal
medium for 10 min, and transferred for in-vitro- or CAM-culture.
In-vitro culture
Individual thawed pieces of two experimental groups (Fig. 1)
(Group 1: medulla-free cortex and Group 2: medulla-contained
CAM-Culture of Cryopreserved Human Ovarian Tissue
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(Cellstar, Greiner Bio-One GmbH, Germany) with 30 ml of AIM-
V medium (Gibco/Invitrogen, USA). They were incubated for 8
days at 37uCi n5 %C O 2 with 75 osc/min agitation using a
rotation shaker.
CAM-culture
Fertilized eggs of White Leghorn chickens, purchased at a local
hatchery and incubated at 37uC with 60% relative humidity, were
prepared for implantation on day 4 of incubation. Standard
microbiology assessment was performed to exclude subclinical
infections. Preparation of the chorio-allantoic membranes was
performed essentially as previously described [50,54–56]. Each
egg was washed with warm 70% ethanol, after which a hole was
drilled through the pointed pole of the shell. The following day,
part of the chorio-allantoic membrane of the embryo was exposed
by peeling a 1.5–2.0 cm window in the shell. This window was
covered with tape and the incubation continued. The chorio-
allantantoic membrane has two epithelial layers and, in its intact
form, represents a ‘‘dry’’ impermeable barrier for all invasions,
including ovarian fragments. For ‘‘connection’’ of ovarian pieces
with the egg system, the latter must be open. To this end, the
upper peridermal part of the double epithelial layer was removed
in each egg, leaving the basal layer intact. On day 10 of incubation
a silicone ring 0.5 mm thick with a 5 mm inner diameter was
placed on the membrane. An ovarian piece was placed into this
silicone ring using microsurgical forceps (Fig. 2). Thereafter, the
shell window was covered again, and the egg replaced in the
incubator. After 5 days of CAM-culture the survival rate of the
ovarian piece was evaluated.
Histology of follicles
For histological investigation, the cultured tissue pieces were
fixed in Bouin’s solution, embedded in paraffin wax, serially
sectioned at 4 mm, stained with hematoxylin/eosin, and analyzed
under a microscope (6400, Olympus Co, Tokyo, Japan).
The number of viable and degenerated follicles was counted.
Before counting of follicles, sections were coded and scored
‘‘blind’’. To avoid overcounting of the same follicles, only the
section with a visible oocyte nucleus was counted.
Morphology of follicles was evaluated on the basis of parameters
previously described by Paynter et al. [57]. Two types of follicles
were evaluated: 1) primordial follicles composed of an oocyte
surrounded by a layer of flattened follicular cells and 2) primary
and secondary follicles which are similar to primordial follicles, but
in which the oocyte is surrounded by one to two layers of spheroid
granulosa cells. The quality of follicles was graded on the scale
from one to three. A follicle of grade 1 is spherical in shape and
contains a spherical oocyte which is surrounded by an even
distribution of granulosa cells and has a homogenous cytoplasm
and slightly granulated nucleus, with condensed chromatin in the
form of a dense spherical structure detectable in the center of the
nucleus. A follicle of grade 2 has similar characteristics, but the
oocyte is without condensed chromatin within the nucleus and is
often irregular in shape; the surrounding granulosa cells can be flat
and pulled away from the edge of the follicle. A follicle of grade 3
contains a misshapen oocyte with or without nuclear vacuolation;
theca and granulosa cells are separated from the edge of the follicle
and the partly or fully disrupted granulosa have pyknotic nuclei.
Follicles of grades 1 and 2 were denoted as normal and those of
grade 3 were denoted as degenerated. Examples of the different
follicular degenerations can be observed elsewhere (for example,
see Isachenko et al. [40,43,45,47,48].
Immunohistology for angiogenesis
Ovarian tissue pieces after culture were fixed in 4.0%
formaldehyde, embedded in paraffin wax, serially sectioned at
4 mm and stained with antibodies (Dako, Hamburg, Germany)
directed against von Willebrand factor (1:100) and desmin (1:100).
The intensity of the immunoreactivity was semiquantitatively
scored by Khan-Dawood et al. [58] as follows: lack of
immunoreactivity (2), weak immunoreactivity (+), moderate
immunoreactivity (++), strong immunoreactivity (+++).
In such way, the rate of vascularisation using von Willebrand
factor was estimated subjectively according to the apparent surface
area of blood vessels in tissue pieces, expressed as a percentage.
With evaluation of neo-vascularisation, the presence of desmin
expression in tissue was taken as ‘‘1’’, the absence of this
expression was taken as ‘‘0’’.
Statistical analysis
Post-thawing integrity rate on the parameters assessed above
were evaluated by ANOVA. Normality of the distribution was
checked. Various characteristics were summarized by mean and
SD within groups. The level of statistical significance was set at a
P,0.05.
Results
The survival rate of the chick embryos was 97.2% (70 of 72).
After 8 days in in-vitro culture as well as 5 days after transfer
onto the extra-embryonic vascular system of the chorioallantoic
membrane, the ovarian fragments were observed to have
developed a spherical shape (Fig. 1).
After completion of CAM-culture (on the fifth day) the
propagation of ovarian pieces in the mesenchymal layer of the
membrane was noted (Fig. 2). The number of distended blood
vessels in the membrane near or next to the implanted ovarian
Figure 1. Cryopreserved ovarian medulla-free and medulla-
containing ovarian pieces after thawing and 8 days in vitro
culture. (a, b) medulla-free piece, (a) just after thawing, (b) the same
piece after culture, (c, d) medulla-containing piece, (c) just after
thawing, (d) the same piece after culture. Bar=1 mm.
doi:10.1371/journal.pone.0032549.g001
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capillaries within close proximity of the implanted fragments
supports the notion of their development (Figs. 2).
Histology of follicles
Histological examination after the 8-day in-vitro culture and 5-
day CAM-culture of ovarian pieces showed that the preantral
follicles were viable. All antral follicles were degenerated after
cryopreservation and culture, and were not counted. The mean
preantral (primordial, primary and secondary) follicle density per
1m m
3 was 14.063.1, 12.762.2, 13.764.4, 12.061.2 for groups
1, 2, 3 and 4, respectively (P.0.1). Moreover, for groups 1, 2, 3
and 4 respectively, 85.061.8%, 85.063.7%, 87.062.8% and
84.060.9% of the follicles were of normal quality (grade 1 and 2)
(P.0.1). There were no statistically significant differences in
percentages of normal follicles between the four groups (P.0.1),
thus morphological quality of follicles was independent of the
conditions of culture and presence or absence of medulla (Figs. 3,
4).
Immunohistology for angiogenesis
There were no differences detected between groups 1 and 3 (in-
vitro cultured medulla-free cortex and CAM-cultured medulla-free
cortex, respectively) with respect to the presence of developed
blood vessels as detected with anti-vWF).
Figure 5 shows representative appearances of vascularisation in
frozen-thawed tissues.
The following rates of this immunoreactivity were observed:
Group 1 (medulla-free cortex cultured in vitro): weak (+);
Group 2 (medulla-containing cortex cultured in vitro): moderate
(++);
Group 3 (medulla-free cortex cultured in CAM-system):
moderate (++);
Group 4 (medulla-containing cortex cultured in CAM-system):
strong (+++).
In groups 1 and 3, the degree of vascularisation (as estimated
subjectively according to the surface area occupied by the blood
vessels) was about 40%, whereas this rate was about 70% in groups
2 and 4 (in-vitro cultured medulla-containing cortex and CAM-
cultured medulla-containing cortex, respectively) (P,0.05) (Fig. 5).
Figure 2. Cryopreserved ovarian medulla-free and medulla-containing pieces before and after 5 days culture with chorioallantoic
membrane (CAM) system. (a, b, c, d, e) medulla-free piece, (a, b) just after thawing and seeding on CAM marked by silicone ring, (c, d, e) the same
piece after culture, (c) piece on CAM, (d, e) piece in Petri dish; (f, g, h, i, j) medulla-containing piece, (f, g) just after thawing and seeding on CAM
marked by silicone ring, (h, i, j) the same piece after culture, (c) piece on CAM, (d, e) piece in Petri dish; (e) outer CAM-layer with medulla-free piece, (j)
inner CAM-layer with medulla-containing piece. Different intensiveness of the avian vascularisation in the place of the seeding of pieces was noted:
(e) versus (j). Bar=1 mm.
doi:10.1371/journal.pone.0032549.g002
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frozen-thawed tissues.
Neo-angiogenesis (detected with anti-desmin) was observed only
in Group 4 (CAM-cultured medulla-contained cortex) (Fig. 6). In
tissue of groups 1, 2 and 3 this process was not observed.
Discussion
The object of this study was two-fold. Firstly we wished to
compare two methods of culture, in vitro-culture.and culture on
the embryonic chorioallantois membrane (CAM) of fertilized
chicken eggs as a means of assessing the quality of cryopreserved
Figure 3. Quality of follicles (expressed as quantity and percentage of normal follicles) after in vitro and CAM-culture of
cryopreserved ovarian pieces. Respective rates are not statistical different (P.0.1).
doi:10.1371/journal.pone.0032549.g003
Figure 4. Histological micrographs of follicles from cryopreserved ovarian tissue after in vitro- and CAM-culture. (a, A) in vitro culture,
(b, B) CAM culture. Bar=25 mm.
doi:10.1371/journal.pone.0032549.g004
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culture the survival of cryopreserved medulla-containing tissue
with that of medulla-free tissue.
The chorioallantoic membrane system is a simple inexpensive
method. The extraembryonic vessel system of the chick chorio-
allantois membrane is naturally immunodeficient, similar to the
mammalian placenta which is also not innervated. Moreover the
embryonic neural and immune systems have not yet developed in
the first half of the normal chick development period. Because of
Figure 5. Vascularisation (von Willebrand factor expression) in
cryopreserved medulla-containing ovarian tissue after in vitro
and CAM-culture. Immonostained after in vitro (a, A) and CAM (b, B)
culture. Bar=0.25 mm.
doi:10.1371/journal.pone.0032549.g005
Figure 6. Neo-angiogenesis (desmin expression) in cryopre-
served medulla-containing ovarian tissue after CAM-culture.
(rectangles) places where neo-angiogenesis was detected, (head arrow)
CAM. Bar=25 mm.
doi:10.1371/journal.pone.0032549.g006
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xenotransplantation of different types of cells from different
species.
The CAM-System is used to study angiogenesis in tumour [59]
and endometriosis tissues [60]. CAM also been used for culture of
human skin [55], liver [61] and skeletal muscle tissue [62], for
surgical retinal research [63], for testing of different biomaterials in
tissue engineering [64] and also for investigations of a bright
spectrum on biological objects [65].
In CAM-culture of bovine and murine ovarian tissue, reported
by Cushman et al. [66] and Gigli et al. [67] respectively,
primordial follicles in the transplanted ovarian tissue retained the
ability to activate and grow. These authors believe that the
extracellular matrix constitution of CAM is similar to the
peritoneum, to which human ovarian tissue can be transplanted
via intraperitoneal xenotransplantation and orthotopic autotrans-
plantation.
Our results indicate that the morphological quality of follicles
was independent of the conditions of culture and of the presence
or absence of medulla. Thus the CAM system is not disadvan-
tageous in this respect.
The first stage in ovarian tissue cryopreservation has usually
been the isolation of cortex from medulla [7]. This procedure
allows the cryopreservation of primordial follicles, which are small
and cryo-resistant structures [68,69]. Usually 1–2 mm slices of
cortex are prepared without medulla.
However, the ovarian medulla has two crucial characteristics:
the presence of follicles and the presence of blood vessels. Follicle
density in the medulla can reach 9824 follicles/gram of medulla,
and considerable numbers of pre-antral follicles are lost when
discarding the medulla during the current practice of isolating the
cortical tissue for cryopreservation [34].
Why medulla-mediated promotion of neovascularization is
advantageous for re-implanted ovarian cortex?
What advantage neo-vascularization is going to add to the
preservation and/or development of follicles after transplantation?
The presence of blood vessels is a very important factor for
successful ovarian graft transplantation as it is required for the
rapid establishment of the blood supplies crucial for the survival of
ovarian follicles [70]. It was showed that transplanted immature
rat ovaries become profusely re-vascularised within 48 h after
autotransplantation [71]. In the cortex, development of primordial
follicles are fully dependent on stromal vessels [72]. Prior to re-
vascularisation, implants are vulnerable to ischaemia, which is the
main obstacle for the survival of tissue after transplantation. Such
damage can lead to a 30 to 70% reduction in graft size
accompanied with fibrotic changes [73]. The hypoxia observed
during the first 5 days after grafting and ischaemic damage
occurring during this period could induce primordial follicle loss
[74–76] and disorders of follicular activation [11,77].
The presence of medullary material in ovarian cortex pieces
could be expected to improve the chances of revascularization of
transplanted ovarian tissue. In examining the histology of our
cultured ovarian fragments, we therefore sought expression of Von
Willebrand factor and desmin.
Von Willebrand factor (vWF or factor VIII-related antigen) is a
blood adhesive and multimeric glycoprotein [78] involved in
hemostasis [79], which mediates platelet adhesion to sub-
endothelium at sites of vascular injury and binds and stabilizes
factor VIII in the circulation [80,81]. It is synthesized in
endothelial cells [82]. Most recently, it was hypothesized that
vWF regulates angiogenesis [83]. However, in immunohistochem-
istry, the staining intensity of vWF is dependent on the blood vessel
size; the most prominent expression of vWF is displayed in veins,
followed by arteries, arterioles, capillaries, and venules [84,85].
In fact, neo-vascularization begins with the formation of very
small vessels. Thus, to detect the formation of these vessels we have
used desmin. Desmin is presenting during the initial development
of vessel sprouts and exhibits differential staining patterns during
vessel formation [86]. Pericytes, connective tissue cells that occurs
about small blood vessels [87], appear to be involved in the earliest
stages of capillary sprouting and were regularly found lying at and
in front of the advancing tips of endothelial sprouts. It was
investigated the participation of microvascular pericytes in the
process of capillary sprouting. Capillary sprouts were visualized by
staining with rhodamine-conjugated phalloidin and pericytes were
simultaneously stained by an antibody to desmin. It was
established that developing pericytes were clearly reactive for
desmin [88].
The presence of desmin-positive cells at the early stage of
vascularization can be shown by the following results [89]. The
angiogenesis induced after implantation of carcinoma fragments
was investigated. The vascular development, which was clearly
concentrated in a dense rim around the tumour, suggests an
acquisition of vasculature by the tumour through vessel incorpo-
ration. Initially, scattered desmin-positive cells were found in the
developing angiogenic rim. Later many desmin-positive cells,
which were identified by electron microscopy as pericytes, were
found around vessels and exhibited close local contacts with
endothelial cells. Later however, after incorporation of the
peritumour vascular rim into the tumour, the number of pericytes
decreased [89].
Our subjective observations support the notion that the rate of
vascularisation (detected with anti-vWF) was higher in medulla-
containing cortex than in medulla-free cortex, regardless of culture
system. Moreover, we observed neo-angiogenesis (detected with
anti-desmin) only in CAM-cultured medulla-containing cortex.
Overall, our preliminary results as presented here lead to three
conclusions. Firstly, they support the observation by Martinez-
Madrid et al. [50] that the CAM system can be used for culturing
cryopreserved human ovarian tissue. Secondly, it appears that the
presence of medullar material in the ovarian pieces leads to better
vascularization and is crucially needed for neo-angiogenesis; it can
be inferred that inclusion of medulla would be of important
advantage when such pieces are re-implanted into their female
sources. Thirdly, only culture in the CAM system led to neo-
angiogenesis in the medulla-containing pieces. For medical
practice it is recommended for evaluation of post-warming
ovarian tissue to use the CAM-system as a valuable alternative
to xenotransplantation and for cryopreservation of these tissues to
prepare ovarian medulla-contained strips.
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